These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27620172)

  • 1. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
    Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
    J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antiproliferative activity of new half-sandwich arene Ru(II) thiophene based aroylhydrazone complexes.
    Prabaharan R; Arunachalam A; Rengan R
    Dalton Trans; 2024 Aug; 53(32):13469-13477. PubMed ID: 39069794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium (II) complex cis-[Ru
    Costa MS; Gonçalves YG; Borges BC; Silva MJB; Amstalden MK; Costa TR; Antunes LMG; Rodrigues RS; Rodrigues VM; de Faria Franca E; Zoia MAP; de Araújo TG; Goulart LR; Von Poelhsitz G; Yoneyama KAG
    Sci Rep; 2020 Sep; 10(1):15410. PubMed ID: 32958783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
    Thangavel SK; Mohamed Kasim MS; Rengan R
    Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis.
    Tang H; Guo X; Yu W; Gao J; Zhu X; Huang Z; Ou W; Zhang H; Chen L; Chen J
    J Inorg Biochem; 2023 Sep; 246():112295. PubMed ID: 37348172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Ru(II) complexes modulate the antioxidant transcription factor Nrf2 to overcome cisplatin resistance.
    Chen L; Tang H; Hu T; Wang J; Ouyang Q; Zhu X; Wang R; Huang W; Huang Z; Chen J
    J Inorg Biochem; 2024 Oct; 259():112666. PubMed ID: 39029397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-tumor activities of three newly designed organotin(IV) carboxylates complexes.
    He J; Wang Y; Su C; Hu Y; Hu W; Hu L; Wang H
    J Inorg Biochem; 2024 Sep; 258():112609. PubMed ID: 38820620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic (
    Wise DE; Gamble AJ; Arkawazi SW; Walton PH; Galan MC; O'Hagan MP; Hogg KG; Marrison JL; O'Toole PJ; Sparkes HA; Lynam JM; Pringle PG
    Dalton Trans; 2020 Nov; 49(43):15219-15230. PubMed ID: 33021299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of ruthenium(II) polypyridyl complexes with human telomeric DNA.
    Tran VT; Turek-Herman J; Ferreira M; Martin KN; Beseiso D; Williams BR; Rosu F; Gabelica V; Burgmayer SJN; Yatsunyk LA
    J Inorg Biochem; 2023 Dec; 249():112388. PubMed ID: 37837940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the cytotoxicity of dinuclear Ru(II) 
    Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
    Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.
    Zhang GD; Wang MM; Su Y; Fang H; Xue XL; Liu HK; Su Z
    J Inorg Biochem; 2024 Jul; 256():112574. PubMed ID: 38677004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on nucleic acid (CT-DNA and yeast tRNA) binding behaviors and cytotoxic properties of a heterodinuclear Ru(II)-Co(III) polypyridyl complex.
    Liang X; Zou X; Tan L; Zhu W
    J Inorg Biochem; 2010 Dec; 104(12):1259-66. PubMed ID: 20837360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of light irradiation on a nitro-ruthenium porphyrin complex in the induced death of lung cancer cells in two- and three-dimensional cultures: Insights into the effect of nitric oxide.
    Becceneri AB; Martin MT; Graminha AE; Cominetti MR; Ford PC; Santana da Silva R
    Dalton Trans; 2024 Jul; 53(27):11264-11275. PubMed ID: 38695514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells.
    Zeng L; Chen Y; Liu J; Huang H; Guan R; Ji L; Chao H
    Sci Rep; 2016 Jan; 6():19449. PubMed ID: 26763798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
    Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
    ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosome-targeted ruthenium(II) complex encapsulated with pluronic
    Pan N; Zhang Y; Huang M; Liang Z; Gong Y; Chen X; Li Y; Wu C; Huang Z; Sun J
    J Biol Inorg Chem; 2024 Mar; 29(2):265-278. PubMed ID: 38189962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation.
    Wang CZ; Wan C; Li CH; Liang GG; Luo Y; Zhang CF; Zhang QH; Ma Q; Wang AH; Lager M; Jiang TL; Hou L; Yuan CS
    Cancer Chemother Pharmacol; 2024 May; 93(5):411-425. PubMed ID: 38191768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Responsive, Self-Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death.
    Lu Y; Zhu D; Hu B; Chen R; Wang X; Xu X; Wang W; Wu H; Wang Y
    Small; 2024 Jun; 20(24):e2310636. PubMed ID: 38412413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetastatic activity of (arene)ruthenium(II) complex of 4-aryl-4H-naphthopyran.
    Pracharova J; Cyrikova T; Berecka M; Biersack B; Kasparkova J; Brabec V
    Chem Biol Interact; 2024 Sep; 400():111180. PubMed ID: 39089413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the anticancer potential of 4-phenylthiazole derived Ru(II) and Os(II) metalacycles.
    Getreuer P; Marretta L; Toyoglu E; Dömötör O; Hejl M; Prado-Roller A; Cseh K; Legin AA; Jakupec MA; Barone G; Terenzi A; Keppler BK; Kandioller W
    Dalton Trans; 2024 Mar; 53(12):5567-5579. PubMed ID: 38426897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.